Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Hiv at 40 video
View:
Comment by qwerty22 on Dec 01, 2021 10:19am
In case people don't know ITN is the leading commercial network TV company in the UK, behind the bbc. Possibly the leading production company in uk TV. It's a helluva step up from that recent video they put out!
Comment by SPCEO1 on Dec 01, 2021 10:33am
Completely at the opposite end of spectrum from a production values perspective. I wonder what the back story for this is? You likely saw the three names on the screen at the start of the video - did they sponsor it? Was this part of an effort to get TH's brand established in the UK before Trogarzo is launched there?
Comment by qwerty22 on Dec 01, 2021 11:07am
Terrence Higgins trust is the biggest uk hiv charity, dating back to the start of the disease. They've certainly partnered with the biggest names. Seems like Paul's approach to marketing is to engage with stakeholders. I remember when he first joined thtx reading about  his views on the rare disease space which he came from, the trick was engagement with the community. You can ...more  
Comment by qwerty22 on Dec 01, 2021 11:19am
This is about fostensavir "Currently, the demand for drugs to use in multidrug resistance in the UK is too limited for a full NICE evaluation. Access however, will be available based on NHS recommendations from specialist HIV commissioning."   Suggests NICE won't be evaluating either this drug or Trogarzo, which means NHS access is through specialists filling out ...more  
Comment by Wino115 on Dec 01, 2021 11:24am
Yes, professional production and good PR, even if the THTX guy is talking like the reporter is his hard to hear grandmother from a foreign country.
Comment by qwerty22 on Dec 01, 2021 11:41am
Found this new research while searching. https://www.natap.org/2021/EACS/EACS_29.htm Not sure what the motivation was for VIIV to do this work but I guess it suggests Trogarzo and Fos are non-inferior to each other.
Comment by qwerty22 on Dec 01, 2021 11:45am
Also emphasizes the extent to which both drugs depended on each other thru the clinical development process. I wish that would extend to the experience in the clinic.
Comment by qwerty22 on Dec 01, 2021 11:49am
There was another recent Viiv paper that re-emphasizes the lack of cross-resistance between the two drug.  https://journals.lww.com/aidsonline/Abstract/9000/Clinical_evidence_for_a_lack_of_cross_resistance.96298.aspx Everything screams that people with no other options should really be on both drugs. I hope that doctors draw that conclusion.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities